Neonatal hypoglycaemia Pregnancy and Childbirth Other neonatal hypoglycaemia
Conditions
Interventions
Current interventions as of 01/02/2022:
Participating hospitals will be randomised:
1. Medical leader to implement a guideline on oral dextrose gel to treat neonatal hy
Sponsors
University of Auckland
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Doctors and midwives attached to New Zealand maternity hospitals with >50 births/year where babies are at risk of neonatal hypoglycaemia (infant of a diabetic, late preterm, small or large for gestational age) are delivered, including hospitals where oral dextrose gel is currently in use.
Exclusion criteria
Exclusion criteria: Hospitals in NZ without a doctor (paediatrician or general practitioner) available to provide medical treatment, or no midwifery care for newborn babies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change in the proportion of eligible hypoglycaemic babies treated with dextrose gel before implementation of the dextrose gel guideline to three months after implementation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 01/02/2022: 1. Proportion of eligible babies admitted to NICU for at least 4 hours 2. Proportion of eligible babies given formula as a treatment for hypoglycaemia during hospital admission 3. Amount of dextrose gel used in the hospital 4. Prolonged uptake of dextrose gel (change in proportion of eligible babies treated with dextrose gel before implementation of the guideline to 6 months after implementation) 5. Sustained use of dextrose gel (change in proportion of eligible babies treated with dextrose gel from 3 months after implementation to 6 months after implementation) 6. Successful treatment with oral dextrose gel on the blood test taken immediately following dextrose gel treatment 7. Adherence to the 'oral dextrose gel to treat neonatal hypoglycaemia guideline' 8. Breastfeeding at discharge Previous secondary outcome measures: 1. Proportion of eligible babies admitted to NICU for at least 4 hours 2. Proportion of eligible babies given formula as a treatment for hypoglycaemia during hospital admission 3. Amount of dextrose gel used in the hospital 4. Initial uptake of dextrose gel (change in proportion of eligible babies treated with dextrose gel before implementation of the guideline to 1 month after implementation) 5. Sustained use of dextrose gel (change in proportion of eligible babies treated with dextrose gel from 1 month after implementation to 3 months after implementation) 6. Successful treatment with oral dextrose gel on the blood test taken immediately following dextrose gel treatment 7. Adherence to the 'oral dextrose gel to treat neonatal hypoglycaemia guideline' 8. Breastfeeding at discharge | — |
Countries
New Zealand
Outcome results
None listed